Pharmacology of MDMA in humans
by
de la Torre R, Farre M, Roset PN, Hernandez Lopez C,
Mas M, Ortuno J, Menoyo E, Pizarro N, Segura J, Cami J
Pharmacology Unit,
Institut Municipal d'Investigacio Medica,
Universitat Autonoma de Barcelona, Spain.
rtorre@imim.es
Ann N Y Acad Sci 2000; 914:225-37


ABSTRACT

MDMA given at recreational doses (range tested 50 to 150 mg) to healthy volunteers, produced mydriasis and marked increases in systolic and diastolic blood pressure, heart rate, and pupillary diameter. MDMA induced changes on oral temperature. The time course of this observation was biphasic, as a slight decrease at 1 h and a slight increase at 2 and 4 h were observed. MDMA induced a slight dose-dependent impairment on psychomotor performance. MDMA produced a marked rise in plasma cortisol and prolactin concentrations. The elimination half-life of MDMA was about 8-9 h. Drug concentrations increased, and a parallel increase in physiologic and hormonal measures was observed. Both peak concentrations and peak effects were obtained between 1 and 2 h and decreased to baseline values 4-6 h after drug administration.


History
Serotonin
Ecstatic rats
Serotonin dip
Controversies
Alexander Shulgin
Human pharmacology
The pharmacology of Ecstasy
Behavioral pharmacology of MDMA


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family